To include your compound in the COVID-19 Resource Center, submit it here.

Nov. 20 Financial Quick Takes: Diagnostics play Lucence raises series A; plus Novo-Broad, PMV, Phoenix, Winterlight and BMS-Celgene

A*STAR spinout Lucence raises $20M
IHH led a $20 million series A round for Lucence, a blood-based cancer diagnostics company spun out of Singapore’s Agency for Science, Technology and Research (A*STAR) in 2016. The company launched next-generation sequencing test LiquidHALLMARK this year; it is designed to detect cancer-related

Read the full 479 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE